The popular and experimental drugs called peptides received unprecedented attention last month during a marathon hearing held by a panel that advises the Food and Drug Administration.

An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.

(Image credit: Catherine Falls Commercial)

Continue reading

Read the full report at NPR News

NPR News supplies a brief version of this story through its feed. Continue to the original publication for the complete report.

Read the original at NPR News